Get started
Author

Mohammad Masoudi

Observed names: Mohamad Masoudi, Mohammad, Masoudi
ORCID: 0000-0001-9434-1524
Observed ORCID: 0000-0001-9434-1524
OpenAlex ID: A5060088337
YAP and TAZ, Hippo Signaling Targets, Act as a Rheostat for Nuclear SHP2 Function
2013 · Ryouhei Tsutsumi, Mohammad Masoudi, et al. · Developmental Cell · 103
PDF
A genome-scale CRISPR/Cas9 knockout screening reveals SH3D21 as a sensitizer for gemcitabine
2019 · Mohammad Masoudi, Motoaki Seki, et al. · Scientific Reports · 15
PDF
Natural resistance to cancer: A window of hope
2023 · Mohammad Masoudi, Parisa Torabi, et al. · International Journal of Cancer · 2
Lessons from a genome-wide CRISPR-Cas9 screening: what researchers should know before start
2021 · Mohammad Masoudi · EXCLI journal · 2
Conditioned media from human pluripotent stem cell‐derived cardiomyocytes inhibit the growth and migration of lung cancer cells
2023 · Hanieh Sadeghi, Mohamad Masoudi, et al. · Journal of Cellular Biochemistry · 1
PDF
Inhibitory Effects of Cannabis sativa Seed Extract on the Pancreatic Cancer Cell Line PANC-1
2026 · Fatemeh Salah, Mohammad Masoudi, et al. · Journal of Human Environment and Health Promotion
PDF
SH3D21 rs34416442 genetic variation is associated with pancreatic cancer patients' overall survival and their response to gemcitabine.
2026 · Mohammad Masoudi, Negin Ahangarian, et al. · PubMed Central
PDF
Analyzing Cinnamon Spice Adulteration with Spectroscopy: The Influence of Data Preprocessing on Multivariate Prediction Models
2025 · Mohammad Masoudi, Rasool Khodabakhshian, et al. · Murdoch University Research Portal
PDF
ゲノムワイドCRISPR/Cas9 スクリーニングによる膵癌におけるgemcitabine作用調節因子の研究
2020 · Mohammad, Masoudi · Institutional Repositories DataBase (IRDB)
Works count: 9
Citation count: 123
H-index: 2
I10-index: 2
Year
Topic
Type